Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life".
J. Clin. Med.
2019,
8
, 1066
J Clin Med
.
2020 Apr 24;9(4):1224.
doi: 10.3390/jcm9041224.
Authors
Domenico Russo
1
,
Rocco Tripepi
2
,
Fabio Malberti
3
,
Biagio Di Iorio
4
,
Bernadette Scognamiglio
1
,
Luca Di Lullo
5
,
Immacolata Gaia Paduano
1
,
Giovanni Luigi Tripepi
2
,
Vincenzo Antonio Panuccio
6
Affiliations
1
Department of Public Health, University of Naples FEDERICO II, 80131 Naples, Italy.
2
Institute of Clinical Physiology (IFC-CNR) Research Unit of Reggio Calabria, 89124 Reggio Calabria, Italy.
3
Department of Nephrology Cremona Hospital, 26100 Cremona, Italy.
4
Department of Nephrology AORN Cardarelli, 80131 Naples, Italy.
5
Department of Nephrology Ospedale "Parodi Delfino" di Colleferro (Roma), Colleferro, 00034 Roma, Italy.
6
Nephrology, Dialysis and transplantation Unit G.O.M. "Bianchi Melacrino Morelli", 89121 Reggio Calabria, Italy.
PMID:
32344506
PMCID:
PMC7230265
DOI:
10.3390/jcm9041224
Abstract
The authors wish to make the following corrections to the previous publication [...].
Publication types
Published Erratum